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The PARO seal: weighing up    
The PARO robotic seal can improve the wellbeing of people with dementia, but is it safe for use on hospital
wards? Kathy Martyn and colleagues carried out research and found that it passed hygiene tests. But
Carlene Rowson and her collaborators claim (opposite) that infection control concerns have not been
adequately answered. In this debate, they argue the case for and against PARO on hospital wards
To test whether the PARO robotic seal issufficiently hygienic to be used bypeople with dementia on a hospital
ward, we introduced it in a stand-alone 10
bedded dementia unit in Sussex NHS
mental health services. Patients were
experiencing a severity of behaviour that
resulted from emotional, psychological and
behavioural distress.  
The unit uses a range of non-
pharmacological approaches where
possible to alleviate distress and improve
wellbeing. PARO is a socially assistive robot
now found in over 35 other countries but
relatively new in the UK. Emerging
evidence shows that it promotes emotional
wellbeing, speech and communication, and
mood and social connection (Moyle et al
2017). 
Translating innovations, such as PARO,
from research into everyday practice may
be slow, requiring attention to the local
context and how to facilitate staff
engagement (Wilson et al 2017; Rycroft-
Malone et al 2013; Brooker et al 2017;
Brownson et al 2017). Our Sussex PARO
project was attentive to the need to research
the process of introduction and be open to
any issues that might arise. 
Three years ago, we became aware of
some hesitancy in the UK and other places
(Canada, Australia) about microbiological
and hygiene aspects of PARO. In some
areas, this led to PARO being blocked by
people from an infection prevention control
perspective.  It is what we have termed a
“hard to clean device”, as it cannot be
cleaned in the same way as other items of
equipment used in the NHS.  
There have been four stages to our
project, which began in 2014, supported by
the National Institute for Health Research
and a consultation group of people with
dementia and carers.  First, we trained and
developed staff in good practice with
PARO; second, we developed protocols for
using it safely and therapeutically; third, we
captured data on its use by patients, carers
and staff; and fourth, we refined guidance
for using the robot, safely cleaning it, and
testing levels of contamination of a new
PARO under clinical conditions.
As a result of our project the infection
prevention control protocols covering the
dementia unit were revised in consultation
with the local infection control specialist. In
particular, the risk and safety protocol now
includes the parameters within which it is
considered safe to use PARO and is clear
about not using it where people on the unit
have transmissible infections such as
MRSA, influenza, diarrhoea and vomiting,
or open wounds.
We conducted monthly random testing
of the cleanliness of PARO, our findings
indicating that it remained within the
acceptable limits of cleanliness demanded
by the Department of Health (2015;
Hygiena 2012). The cleaning and testing
procedure we devised is in accordance with
NICE guidance (2011) and our work
adhered to requirements for NHS settings.
We invite further work for other settings.
PARO presents an interesting example of
a hard to clean device. We were guided by
principles of “responsible innovation”
(Demers-Payette et al 2016), coupled with
the “precautionary principle” taken from
international environmental law (Stirling
2016). The precautionary principle invites
innovators to take steps to demonstrate
something new can be used safely and not
cause severe harm or death (Weckert &
Moor 2006).  
Arguably, inhibiting an innovation
without exploration is problematic, denies
progress in developing new practice, and
might be seen as a case of “paralysis
without analysis”. It would be a shame if
something such as PARO, with apparent
clinical therapeutic benefit, was hindered
because of speculation about how it might
be used and perceptions of hazard and risk
unsupported by evidence from trials. 
In our project we employed an ATP
luminometer, which detects organic matter
on the surface of a device, to measure
cleanliness. We recognise the limitations of
using ATP (an enzyme found in organic
matter) as a surrogate measure for
microbial pathogens in hospital and care
settings (Shama and Malik 2013).  In
recognition of this, the University of
Brighton is widening its investigation and
has begun to undertake analysis in a
laboratory-based inquiry into the contagion
likelihood and further exploration of
cleaning methods.
Finally, it must be emphasised that there
have been no reported transmission
infections associated with the use of PARO
in the UK or worldwide. Based on the
findings of our practice-based study, we
offer our protocols and report freely to
others and would welcome further
discussion and evidence on how to use
PARO safely in practice in a range of
settings. For our report and protocols,
please email K.J.Martyn@brighton.ac.uk.
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So far, the PARO interactive robotic sealhas mainly been used as a therapeuticintervention in care homes.  Now it
has been suggested by researchers at the
University of Brighton that it could be
extended to NHS inpatient wards.
But the nature of the device generates a
number of infection control concerns which
we don’t feel have been adequately
answered.  PARO is used in close contact
with patients, most commonly in a
communal shared setting, and it has an
artificial fur covering, making adequate
decontamination of the device challenging. 
Here in Sheffield, the PARO seal first
swam into the infection prevention and
control (IPC) spotlight back in early 2015.
Infection control implications were raised
when the IPC team were approached to
sanction and support the purchase of PARO
in a local mental health NHS trust which
had been trying it out. Staff at the trust were
unable to give satisfactory assurances that
acceptable and robust cleaning and
decontamination standards were in place,
so purchase was not authorised.  
It is known that common hospital-
acquired (“nosocomial”) pathogens can
survive and persist on inanimate surfaces in
the hospital environment for months and
can be a source of continuous transmission
if surface disinfection is inadequate
(Kramer et al 2006). Items frequently
touched or in close contact with patients
can become contaminated by these
pathogens. 
Contaminated surfaces can serve as a
source of transmission of nosocomial
pathogens by direct spread to susceptible
patients or through hand contamination of
health care workers. There is now
considerable evidence indicating that
environmental transmission plays an
important role with these pathogens,
including methicillin-resistant
staphylococcus aureus, vancomycin-
resistant enterococcus spp, norovirus,
clostridium difficile and influenza (Weber et
al 2010; Otter et al 2013, 2016).
For a vulnerable elderly population with
dementia and perhaps other conditions,
living closely together on a hospital ward,
the risks and consequences of transmission
are increased.   The IPC team has yet to see
demonstrable evidence that, once PARO
has been exposed to nosocomial pathogens,
it can be decontaminated to the extent that
these infectious agents cannot be recovered
from the artificial fur afterwards. In our
view, the University of Brighton’s research
does not go far enough.
Soft toys are notoriously difficult to
decontaminate, with no clear guidelines
existing on best practice. The Department of
Health guidance for decontaminating used
linen recommends a washing process in
which the temperature is maintained on a
disinfection cycle at 71 0 C for three or more
minutes or 65 0 C for 10 or more minutes
(NHS Executive 1995). Data on empathy
dolls, evaluated in our unit, has identified
that clinically significant organisms can
persist on the doll’s surface even after a 60
degrees C wash cycle. 
In light of the cross-contamination risk,
our local protocol for use of empathy dolls
in hospital requires that only one patient
uses it for the duration of their stay.  The
doll must then be washed at 80 degrees C
before re-use with another patient.  If a
patient is known to have an infection
requiring barrier precautions, the doll is not
re-used with another patient at all
(Subramanian et al 2014). 
These practical interventions are not
feasible with PARO. The high cost of the
device makes single use problematic and it
is not suitable for washing at high
temperatures. Chlorine-based wipes could
be used to wipe PARO’s surface, but they
are not licensed for use on soft surfaces and
it is unlikely they would adequately
penetrate the entire depth of the artificial fur. 
There are too few validated
decontamination techniques and
appropriate cleaning products for use on
PARO.  Quantitative microbiological
evidence is needed to provide assurance of
the adequacy of any decontamination
procedures. For example, microbial
monitoring, with aerobic colony counts
before and after cleaning, is an established
method of evaluating the efficacy of routine
cleaning and disinfection practices (Galvin
et al 2012). 
Before PARO and similar robotic animals
are adopted in health care settings, it is vital
that potential infection control issues are
recognised and proactively addressed.
Further enquiry will be necessary to devise
an effective decontamination strategy and
only then will it be possible to introduce it
safely in these settings. n
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